Flora Peyvandi: Personalized VWF Dosing Revolutionizes Surgery in VWD
hemohemoFlora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of ISTH, shared a post on X about a recent article by Mélanie Y. Daniel et al. published in Blood Advances:
“Modeling response to high-purity von Willebrand factor: toward tailored dosing during surgery in von Willebrand disease”
Title: Modeling response to high-purity von Willebrand factor: toward tailored dosing during surgery in von Willebrand disease
Authors: Mélanie Y. Daniel, Antoine Rauch, Camille Paris, Emmanuelle Jeanpierre, Jenny Goudemand, Catherine Marichez, Bénédicte Pradines, Christophe Zawadzki, Annabelle Dupont, Cécile V. Denis, Peter J. Lenting, Sophie Susen, Xavier Delavenne
Read the Full Article on Blood Advances
Find more posts featuring Flora Peyvandi on Hemostasis Today.
-
Oct 9, 2026, 11:29Jigesha Dholakia: Supporting the Hemophilia Community Through the Unite Walk
-
Oct 9, 2026, 11:06Nobles Green: How siRNA Therapy Helps the Body Form Stronger Clots
-
Oct 9, 2026, 10:53Switching From Emicizumab to Denecimig in Hemophilia A – Rare Disease Advisor
-
Oct 9, 2026, 10:40What New U.S. Data Reveal About GT – Glanzmann’s Research Foundation
-
Oct 9, 2026, 10:32Anjali Pandey: The Morphologic Clues to MDS With del(5q)
-
Oct 9, 2026, 10:13Reza Shojaei: 5 Leadership Responsibilities for a Sustainable Plasma Ecosystem
-
Oct 9, 2026, 08:38Johannes Gratz: Perioperative Care in Factor VII Deficiency – Treating the Patient, Not the Number
-
Oct 9, 2026, 08:28Ghanim Fajish: Vascular Cells May Retain a Prothrombotic Memory of Oxidative Stress
-
Oct 9, 2026, 07:43Mehmet Cilingiroglu: The First Diagnosis of Coronary Thrombosis in a Living Patient